A1 Refereed original research article in a scientific journal

Toward a sustainable protection group approach for solid-phase oligonucleotide synthesis employing 5′-O-(2-methoxyisopropyl) protection;




AuthorsSaari, Verneri; Ora, Mikko; Gimenez Molina, Alejandro; Horvath, Andras; Sanghvi, Yogesh S.; Virta, Pasi

PublisherRoyal Society of Chemistry (RSC)

Publication year2026

Journal: Organic and Biomolecular Chemistry

Volume24

Issue29

First page 6082

Last page6091

ISSN1477-0520

eISSN1477-0539

DOIhttps://doi.org/10.1039/d6ob00858e

Publication's open availability at the time of reportingOpen Access

Publication channel's open availability Partially Open Access publication channel

Web address https://doi.org/10.1039/d6ob00858e

Self-archived copy’s web addresshttps://research.utu.fi/converis/portal/detail/Publication/526996114

Self-archived copy's licenceCC BY

Self-archived copy's versionPublisher`s PDF


Abstract

5′-O-(2-Methoxyisopropyl) (MIP)-protected nucleoside-3′-O-phosphoramidites were synthesized and evaluated as novel building blocks for automated solid-phase oligonucleotide synthesis (SPOS). Activators and additives were screened to establish the optimal conditions for the coupling of the 5′-O-MIP building blocks. Approximately half the amount of the deblocking reagent can be used to remove 5′-O-MIP compared to 5′-O-4,4′-dimethoxytrityl (DMT) with twice the rate for its deprotection. The faster 5′-O-deprotection rate reduced overall acid consumption, while the small-molecule benign byproducts (acetone and methanol) generated via MIP deprotection permit a lower PMI during SPOS. This work potentially leverages the improved design of sustainable strategies for the manufacturing of therapeutic oligonucleotides.


Downloadable publication

This is an electronic reprint of the original article.
This reprint may differ from the original in pagination and typographic detail. Please cite the original version.




Funding information in the publication
Financial support from the Doctoral Programme in Exact Sciences (EXACTUS) is acknowledged.


Last updated on 10/08/2026 02:05:40 PM